Microviable core activity is to develop novel biological medicines for unmet challenges in human health, with special focus on multi-drug-resistant infectious diseases, oncology and dermatology. Our products are a result of our proprietary technology and drug development platform, together with a highly qualified team and a growing IP portfolio.
Microviable has received numerous recognitions and awards, including the European Seal of Excellence two times, which adds on top of our network of international collaborations and partnerships with clinicians and scientists. y cuenta con colaboraciones clínicas y de investigación a nivel internacional.
Certifications:
Awards:
English 
Spanish